Clinical Interests
Assessment and treatment of substance use disorders
Tobacco and alcohol addictions in medical and psychiatric patients.
Cancer prevention and control.
Research Interests
Identifying risk factors, biological vulnerability, and co-morbidities in substance use disorders.
Examining efficacy of behavioral and pharmacological treatments for nicotine, alcohol, and other addictive disorders.
Targeting treatments for minority and underserved smokers.
New York Medical College, St. Vincent’s Hospital
Internship
1995
University of Pennsylvania
- Post-doctoral Fellowship
1994
University of Oklahoma Health Sciences Center
Ph.D.
1992
Illinois Licensed Clinical Psychologist
Exposure to JUUL use: cue reactivity effects in young adult current and former smokers.
Vena A, Miloslavich K, Howe M, Cao D, King AC. Exposure to JUUL use: cue reactivity effects in young adult current and former smokers. Tob Control. 2020 May 23.
PMID: 32447316
The future of translational research on alcohol use disorder.
Ray LA, Grodin EN, Leggio L, Bechtholt AJ, Becker H, Feldstein Ewing SW, Jentsch JD, King AC, Mason BJ, O'Malley S, MacKillop J, Heilig M, Koob GF. The future of translational research on alcohol use disorder. Addict Biol. 2020 Apr 14; e12903.
PMID: 32286721
Substance use behaviors in adolescent and young adult cancer patients: Associations with mental and physical health.
Asvat Y, King AC, Smith LJ, Lin X, Hedeker D, Henderson TO. Substance use behaviors in adolescent and young adult cancer patients: Associations with mental and physical health. Psychooncology. 2020 Jun; 29(6):1068-1076.
PMID: 32154963
Real-Time Mobile Monitoring of Drinking Episodes in Young Adult Heavy Drinkers: Development and Comparative Survey Study.
Fridberg DJ, Faria J, Cao D, King AC. Real-Time Mobile Monitoring of Drinking Episodes in Young Adult Heavy Drinkers: Development and Comparative Survey Study. JMIR Mhealth Uhealth. 2019 11 20; 7(11):e13765.
PMID: 31746774
Evaluation of a Randomized Clinical Trial Comparing the Effectiveness of a Culturally Targeted and Nontargeted Smoking Cessation Intervention for Lesbian, Gay, Bisexual, and Transgender Smokers.
Matthews AK, Steffen AD, Kuhns LM, Ruiz RA, Ross NA, Burke LA, Li CC, King AC. Evaluation of a Randomized Clinical Trial Comparing the Effectiveness of a Culturally Targeted and Nontargeted Smoking Cessation Intervention for Lesbian, Gay, Bisexual, and Transgender Smokers. Nicotine Tob Res. 2019 10 26; 21(11):1506-1516.
PMID: 30169797
Relationships between generalized impulsivity and subjective stimulant and sedative responses following alcohol administration.
Berey BL, Leeman RF, Chavarria J, King AC. Relationships between generalized impulsivity and subjective stimulant and sedative responses following alcohol administration. Psychol Addict Behav. 2019 Nov; 33(7):616-625.
PMID: 31497988
The role of alcohol response phenotypes in the risk for alcohol use disorder.
King AC, Cao D, deWit H, O'Connor SJ, Hasin DS. The role of alcohol response phenotypes in the risk for alcohol use disorder. BJPsych Open. 2019 Apr 22; 5(3):e38.
PMID: 31685074
A pilot study of Counsel to Quit®: Evaluating an Ask Advise Refer (AAR)-based tobacco cessation training for medical and mental healthcare providers.
Chavarria J, Liu M, Kast L, Salem E, King AC. A pilot study of Counsel to Quit®: Evaluating an Ask Advise Refer (AAR)-based tobacco cessation training for medical and mental healthcare providers. J Subst Abuse Treat. 2019 04; 99:163-170.
PMID: 30797390
E-cigarette use (vaping) is associated with illicit drug use, mental health problems, and impulsivity in university students.
Grant JE, Lust K, Fridberg DJ, King AC, Chamberlain SR. E-cigarette use (vaping) is associated with illicit drug use, mental health problems, and impulsivity in university students. Ann Clin Psychiatry. 2019 02; 31(1):27-35.
PMID: 30699215
Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial.
Roche DJO, Trela CJ, Argos M, Jasmine F, Kibriya MG, Ahsan H, King AC. Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial. Alcohol Alcohol. 2019 Jan 09; 54(5):559-565.
PMID: 31206155